Refine by
Therapeutic Development Articles & Analysis
172 articles found
As biotechnology and recombinant protein production technologies continue to advance, the development of therapeutic enzymes is expanding beyond traditional applications, offering new possibilities for rare disease treatment. ...
Applications of Transcriptome Analysis The wide application of transcriptomics in biomedical research is of great significance in understanding the basic mechanisms of life, revealing the molecular mechanisms of disease development, and discovering new therapeutic targets and drugs, including the following directions: Analysis of Gene Expression Regulation l ...
Neurotrophic factors are not only essential during development but continue to exert their effects in the adult nervous system. ...
This contextual behavior makes CCR1 a prime candidate for therapeutic modulation. Unlike receptors with highly selective ligand pools, CCR1’s redundancy ensures robustness of immune response but complicates therapeutic targeting. ...
Exercise-induced bronchoconstriction (EIB) is a hallmark of asthma and other respiratory diseases. It occurs when vigorous physical activity triggers transient and reversible airway narrowing. Environmental factors such as cold, dry air and air pollution are known to exacerbate symptoms, particularly in athletes and individuals exercising in urban environments. A recent study by Marain et al. ...
In the realm of modern genetic research, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has emerged as a transformative tool, particularly in the context of target identification for therapeutic development. This innovative approach has revolutionized how scientists understand gene function, enabling high-throughput screening ...
Toward ELANE-Targeted Therapies The balance between ELANE's protective and pathogenic roles has prompted the development of ELANE inhibitors as therapeutic agents. Sivelestat, a small-molecule ELANE inhibitor, has shown promise in acute lung injury but is limited by specificity and bioavailability. ...
By evaluating how compounds affect signaling pathway activity, researchers can identify promising therapeutic agents and assess their efficacy and safety. Understanding Disease Mechanisms: Reporter cell lines can elucidate the roles of specific signaling pathways in disease development and progression. ...
Primary podocyte cultures tend to proliferate for only a brief period, making it difficult to conduct long-term studies on their behavior or response to therapeutic agents. The development of immortalized human podocyte cell lines addresses this issue, providing continuously replicating cells that maintain functional characteristics similar to those found in ...
The ability to study these cells in a laboratory setting has been greatly enhanced through the development of immortalized human ovarian epithelial cell lines, particularly those that utilize the SV40 (Simian Virus 40) large T antigen. ...
These protocols ensure that the AAVs supplied are not only effective but also safe for use in various experimental settings. Advancing Therapeutic Avenues Beyond basic research, optogenetics AAV production services hold significant promise for therapeutic applications. They provide a foundation for developing novel treatments for neurological ...
In cancer research, these vectors allow for the investigation of gene function and the potential development of gene therapies targeting tumor cells. In regenerative medicine, they have the capability to correct genetic disorders by delivering therapeutic genes to affected tissues. Moreover, in model organism studies, CRISPR/Cas9 lentiviral systems are employed ...
With their pivotal role in cellular signaling and function, they have emerged as critical targets in drug discovery and development. As the pharmaceutical and biotech industries continue to invest in novel therapeutic agents, the demand for effective ion channel screening services has surged. ...
This phenomenon is crucial in various contexts, including disease pathogenesis and the development of therapeutic interventions. For instance, when a vaccine elicits an immune response against a pathogen, it is vital to ensure that the generated antibodies do not target similar proteins in the body’s own tissues, as this could result in autoimmune ...
One of the most intriguing aspects has been the role of gene fusions in cancer development and progression. Gene fusions, formed by the joining of two separate genes, often lead to the production of abnormal proteins that can drive tumorigenesis. ...
Recombinant protein expression is a cornerstone of modern biopharmaceutical development, providing the means to produce proteins with therapeutic potential, enzymes, and antibodies. ...
The enzyme classification landscape continues evolving as structural biology, directed evolution, and systems biology provide deeper insights into these remarkable molecular machines and their application potential in addressing contemporary challenges in biomanufacturing and therapeutic development. ...
Additionally, the short half-life of chemokines in vivo and their potential to trigger off-target effects limit their therapeutic window. Another hurdle is the development of chemokine receptor antagonists. ...
One of the key issues is drug resistance. Cancer cells often develop resistance to BCL2 inhibitors by upregulating other anti-apoptotic proteins like MCL1 or BCL-XL. ...
Nanoparticle Research: Characterizing synthetic nanoparticles, establishing size distributions, and evaluating colloidal stability. Pharmaceutical Development: Analyzing liposomes, polymeric nanoparticles, and drug delivery systems for size consistency and stability during storage. ...